{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:34:55Z","timestamp":1761676495664,"version":"3.37.3"},"reference-count":46,"publisher":"Japan Oil Chemists' Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Oleo Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.5650\/jos.ess16204","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T18:23:59Z","timestamp":1491243839000},"page":"443-454","source":"Crossref","is-referenced-by-count":16,"title":["A Novel Chemical Enhancer Approach for Transdermal Drug Delivery with C<sub>17<\/sub>-Monoglycerol Ester Liquid Crystal-forming Lipid"],"prefix":"10.5650","volume":"66","author":[{"given":"Wesam R.","family":"Kadhum","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Hijikuro","sequence":"additional","affiliation":[{"name":"Farnex Incorporated, Tokyo Institute of Technology Yokohama Venture Plaza"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Todo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sugibayashi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3621","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Purdon, C.H.; Azzi, C.G.; Zhang, J.; Smith, E.W.; Maibach, H.I. Penetration enhancement of transdermal delivery-current permutations and limitations. Crit. Rev. Ther. Drug Carrier Syst. 21, 97-132 (2004).","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i2.20"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kasha, P.C.; Banga, A.K. A review of patent literature for iontophoretic delivery and devices. Recent Pat. Drug Deliv. Formul. 2, 41-50 (2008).","DOI":"10.2174\/187221108783331438"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ogura, M.; Paliwal, S.; Mitragotri S. Low-frequency sonophoresis: current status and future prospects. Adv. Drug Deliv. Rev. 60, 1218-1223 (2008).","DOI":"10.1016\/j.addr.2008.03.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tokumoto, S.; Mori, K.; Higo, N.; Sugibayashi, K. Effect of electroporation on the electroosmosis across hairless mouse skin in vitro. J. Control. Release 105, 296-304. (2005).","DOI":"10.1016\/j.jconrel.2005.04.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tokudome, Y.; Sugibayashi, K. Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs. J. Control. Release 95, 267-274 (2004).","DOI":"10.1016\/j.jconrel.2003.12.014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Larsson, K. Aqueous dispersions of cubic lipid\u2013water phases. Curr. Opin. Colloid In. 5, 64-69 (2000).","DOI":"10.1016\/S1359-0294(00)00040-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Caboi, F.; Amico, G.S.; Pitzalis, P.; Monduzzi, M.; Nylander, T.; Larsson, K. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein\/water system. I. Phase behavior. Chem. Phys. Lipids 109, 47-62 (2001).","DOI":"10.1016\/S0009-3084(00)00200-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yamada, K.; Yamashita, J.; Todo, H.; Miyamoto, K.; Hashimoto, S.; Tokudome, Y.; Hashimoto, F.; Sugibayashi, K. Preparation and evaluation of liquid crystal formulation having skin permeation- enhancing ability of the entrapped drug. J. Oleo Sci. 60, 31-40 (2011).","DOI":"10.5650\/jos.60.31"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dae, G.L.; Won, W.J.; Nam, A.K.; Jun, Y.L.; Seol, H.L.; Woo, S.S.; Nae, G.K.; Seong, H.J. Effect of the glyceryl monooleate-based lyotropic phases on skin permeation using in vitro diffusion and skin imaging. Asian J. Pharm. Sci. 9, 324-329 (2014).","DOI":"10.1016\/j.ajps.2014.06.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chen, Y.; Ma, P.; Gui, S. Cubic and hexagonal liquid crystals as drug delivery systems. Biomed. Res. Int. 2014, http:\/\/dx.doi.org\/10.1155\/2014\/815981 (2014).","DOI":"10.1155\/2014\/815981"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Biltonen, R.L.; Lichtenberg, D. The use of differential scanning calorimetry as a tool to characterize liposome preparations. Chem. Phys. Lipids 64, 128-142 (1993).","DOI":"10.1016\/0009-3084(93)90062-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ganem-Quintanar, A.; Quintanar-Guerrero, D.; Buri, P. Monoolein: a review of the pharmaceutical applications. Drug Dev. Ind. Pharm. 26, 809-820 (2000).","DOI":"10.1081\/DDC-100101304"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bode, J.C.; Kuntsche, J.; Funari, S.S.; Bunjes, H. Interaction of dispersed cubic phases with blood components. Int. J. Pharm. 448, 87-95 (2013).","DOI":"10.1016\/j.ijpharm.2013.03.016"},{"key":"14","unstructured":"14) Guo, C.; Wang, J.; Cao, F., Lee, R.J.; Zhai, G. Lyotropic liquid crystal systems in drug delivery. Drug Discov. Today 15, 1032-1040 (2010)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Siddig, M.A.; Radiman, S.; Muniandy, S.V.; Jan, L.S. Structure of cubic phases in ternary systems glucopone\/water\/hydrocarbon. Colloids Surf. A Physicochem. Eng. Asp. 236, 57-67 (2004).","DOI":"10.1016\/j.colsurfa.2004.01.023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Makai, M.; Csanyi, E.; Nemeth, Z.; Palinkas, J.; Eros, I. Structure and drug release of lamellar liquid crystals containing glycerol. Int. J. Pharm. 256, 95-107 (2003).","DOI":"10.1016\/S0378-5173(03)00066-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Fong, W.K.; Hanley, T.; Boyd, B.J. Stimuli responsive liquid crystals provide \u2018on-demand\u2019 drug delivery in vitro and in vivo. J. Control. Release 135, 218-226 (2009).","DOI":"10.1016\/j.jconrel.2009.01.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Clogston, J.; Rathman, J.; Tomasko, D.; Walker, H.; Caffrey, M. Phase behavior of a monoacylglycerol: (myverol 18-99 K) \/water system. Chem. Phys. Lipids 107, 191-220 (2000).","DOI":"10.1016\/S0009-3084(00)00182-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kadhum, W.R.; Todo, H.; Sugibayashi, K. Skin permeation: Enhancing ability of liquid crystal formulations. in Percutaneous penetration enhancers chemical methods in penetration enhancement: Drug Manipulation Strategies and Vehicle Effects (Dragicevic-Curic, N.; Maibach, H. eds.). Springer-Verlag, Berlin Heidelberg, pp. 243-253 (2015).","DOI":"10.1007\/978-3-662-45013-0_17"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Drummond, C.J.; Fong, C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interface Sci. 4, 449-456 (1999).","DOI":"10.1016\/S1359-0294(00)00020-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shah, J.C.; Sadhale, Y.; Chilukuri, D.M. Cubic phase gels as drug delivery systems. Adv. Drug Deliv. Rev. 47, 229-250 (2001).","DOI":"10.1016\/S0169-409X(01)00108-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kaasgaard, T.; Drummond, C.J. Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent. Phys. Chem. Chem. Phys. 8, 4957-4975 (2006).","DOI":"10.1039\/b609510k"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kadhum, W.R.; Oshizaka, T.; Hijikuro, I.; Todo, H.; Sugibayashi, K. Usefulness of liquid\u2013crystal oral formulations to enhance the bioavailability and skin tissue targeting of p-amino benzoic acid as a model compound. Eur. J. Pharm. Sci. 88, 282-290 (2016).","DOI":"10.1016\/j.ejps.2016.04.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Chong, J.Y.T.; Mulet, X.; Waddington, L.J.; Boyd, B.J.; Drummond C.J. High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions. Langmuir 28, 9223-9232 (2012).","DOI":"10.1021\/la301874v"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Spicer, P.T. Progress in liquid crystalline dispersions: cubosomes. Curr. Opin. Colloid Interface Sci. 10, 274-279 (2005).","DOI":"10.1016\/j.cocis.2005.09.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yaghmur, A.; Glatter, O. Characterization and potential applications of nanostructured aqueous dispersions. Adv. Colloid Interface Sci. 148, 333-342 (2009).","DOI":"10.1016\/j.cis.2008.07.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Higuchi, T. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52, 1145-1148 (1963).","DOI":"10.1002\/jps.2600521210"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Anderson, D.M.; Gruner, S.M.; Leibler, S. Geometrical aspects of the frustration in the cubic phases of lyotropic liquid crystals. Proc. Natl. Acad. Sci. USA 85, 5364-5368 (1988).","DOI":"10.1073\/pnas.85.15.5364"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Qiu, H.; Caffrey, M. The phase diagram of monoolein\/water system: metastability and equilibrium aspects. Biomaterials 21, 223-234 (2000).","DOI":"10.1016\/S0142-9612(99)00126-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ericsson, B.; Eriksson, P.O.; Lofroth, J.E.; Engstrom, S. Cubic phases as delivery systems for peptide drugs. ACS Symp. Ser. 469, 252-263 (1991).","DOI":"10.1021\/bk-1991-0469.ch022"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wallin, R.; Engstrom, S.; Mandenius, C.F. Stabilisation of glucose oxidase by entrapment in a cubic liquid crystalline phase. Biocatalysis 8, 73-80 (1993).","DOI":"10.3109\/10242429309030957"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nylander, T.; Mattisson, C.; Razumas, V.; Miezes, Y.; Hakansson, B. A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase. Colloids Surf. A. 114, 311-320 (1996).","DOI":"10.1016\/0927-7757(96)03563-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Caboi, F.; Nylander, T.; Razumas, V.; Talaikyte, Z.; Monduzzi, M.; Larsson, K. Structural effects, mobility, and redox behavior of vitamin K1 hosted in the monoolein:water liquid crystalline phases. Langmuir 13, 5476-5483 (1997).","DOI":"10.1021\/la9702188"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Lopes, L.B.; Speretta, F.F.; Bentley, M. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Eur. J. Pharm. Sci. 32, 209-215 (2007).","DOI":"10.1016\/j.ejps.2007.07.006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wong, J.; Abrishami, A.; El Beheiry, H.; Mahomed, N.N.; Roderick D.J.; Gandhi, R.; Syed, K.A.; Muhammad, O.H.S.; De Silva, Y.; Chung, F. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J. Bone Joint Surg. Am. 15, 2503-2513 (2010).","DOI":"10.2106\/JBJS.I.01518"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Wada, Y.; Ishii, F. Potential power of green tea catechins. J. Oleo Sci. 8, 371-378 (2008).","DOI":"10.5650\/oleoscience.8.371"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Guo, C.; Wang, J.; Cao, F.; Lee, R.J.; Zhai, G. Lyotropic liquid crystal systems in drug delivery. Drug Discov. Today 15, 1032-1040 (2010).","DOI":"10.1016\/j.drudis.2010.09.006"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Siekmann, B.; Bunjes, H.; Koch, M.H.J.; Westesen, K. Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases. Int. J. Pharm. 244, 33-43 (2002).","DOI":"10.1016\/S0378-5173(02)00298-3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Esposito, E.; Eblovi, N.; Rasi, S.; Drechsler, M.; Di Gregorio, G.; Menegatti, E.; Cortesi, R. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSciTech. 5, 1-15 (2003).","DOI":"10.1208\/ps050430"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Sherif, S.; Bendas, E.R.; Badawy, S. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Eur. J. Pharm. Biopharm. 86, 251-259 (2014).","DOI":"10.1016\/j.ejpb.2013.09.008"},{"key":"41","unstructured":"41) Watanabe, T.; Hasegawa, T.; Takahashi, H.; Ishibashi, T.; Takayama, K.; Sugibayshi, K. Utility of the three-dimensional cultured human skin model as a tool to evaluate skin permeation of drugs. AATEX 8, 1-14 (2001)."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Morimoto, Y.; Hatanaka, T.; Sugibayashi, K.; Omiya, H. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J. Pharm. Pharmacol. 44, 634-639 (1992).","DOI":"10.1111\/j.2042-7158.1992.tb05484.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Uchino, T.; Murata, A.; Miyazaki, Y.; Oka, T.; Kagawa, Y. Glyceryl monooleyl ether-based liquid crystalline nanoparticles as a transdermal delivery system of flurbiprofen: characterization and in vitro transport. Chem. Pharm. Bull. 63, 334-340 (2015).","DOI":"10.1248\/cpb.c15-00029"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Esposito, E.; Cortesi, R.; Drechsler, M.; Paccamiccio, L.; Mariani, P.; Contado, C.; Stellin, E.; Menegatti, E.; Bonina, F.; Puglia, C. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm. Res. 22, 2163-2173 (2005).","DOI":"10.1007\/s11095-005-8176-x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Evenbratt, H.; Jonsson, C.; Faergemann, J.; Engstrom, S.; Ericson, M.B. In vivo study of an instantly formed lipid\u2013water cubic phase formulation for efficient topical delivery of aminolevulinic acid and methyl-aminolevulinate. Int. J. Pharm. 452, 270-275 (2013).","DOI":"10.1016\/j.ijpharm.2013.05.047"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Lopes, L.B.; Ferreira, D.A.; de Paula, D.; Garcia, M.T.; Thomazini, J.A.; Fantini, M.C.; Bentley, M.V. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm. Res. 23, 1332-1342 (2006).","DOI":"10.1007\/s11095-006-0143-7"}],"container-title":["Journal of Oleo Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/66\/5\/66_ess16204\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:06:57Z","timestamp":1498385217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/66\/5\/66_ess16204\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5650\/jos.ess16204","relation":{},"ISSN":["1345-8957","1347-3352"],"issn-type":[{"type":"print","value":"1345-8957"},{"type":"electronic","value":"1347-3352"}],"subject":[],"published":{"date-parts":[[2017]]}}}